New Weight-Loss Drug Tirzepatid Is Effective but Unaffordable for Most
says that tirzepatide costs in the mid-$900 to about $1,200 range for four pens without health insurance. However, the cost of the drug “is going to vary depending on insurance,” Alan says.
Stephanie Field, director of pharmacy operations at Corewell Health West, says that patients with type 2 diabetes who qualify for co-pay assistance through Eli Lilly can pay as little as $25 a month. However, that’s for patients who are taking the drug for diabetes—not weight loss.Right now, the drug “is only covered for patients with type 2 diabetes,” Field says, noting that “utilization for weight loss is considered off-label and not covered by a patient’s insurance.
Once tirzepatide is FDA approved, Dr. Ali says it’s “not likely” to be approved by most insurance companies. “If it is, it will be quite expensive for most patients,” he says. “Hopefully, that will change with time.” Field says patients can expect the cost of tirzepatide for weight loss to be similar to that of other similar medications on the market. “There are two GLP-1 medications with weight loss indications approved by the FDA—Saxenda and Wegovy,” Field says. “Cash prices for patients can vary depending on the pharmacy, but averages around $1,000 for a month of medication.”
However, if you have a high level of insurance coverage, Dr. Stanford says the drug may be more affordable. “If not, this would be cost prohibitive,” she adds.It depends. “It depends on your insurance. It also depends on your own personal finances and how important this medication is for you,” Alan says. Once the drug is approved by the FDA, “some insurances might cover it for diabetes or pre-diabetes and not cover it for weight loss,” Alan says.In general, the drug is “fairly safe,” Alan says.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Demand soars as people turn to diabetes, obesity medication for weight lossIs the influence of social media taking much-needed medication out of the hands of diabetics?
続きを読む »
How the 2022 Texans compare to Houston's worst NFL seasons everA loss Sunday would give Houston its fifth 14-loss season by the Texans or Oilers.
続きを読む »
New campaign aims to reduce drug trafficking, overdose deathsThe Alaska High Intensity Drug Trafficking Organization has announced a new campaign of advertisements designed to empower Alaskans to report drug trafficking activity to law enforcement.
続きを読む »
New Marysville ordinance allows police to make arrests for public drug useThe ordinance prohibits the use of controlled substances in public without a prescription.
続きを読む »
Tesla is ringing in the new year with a 10% weekly lossTesla Inc. shares are poised to end the first week of the 2023 with losses of about 10%, deepening the stock's dive in recent months and following news that...
続きを読む »
New Alzheimer’s Drug Approved by FDA, Promises to Slow DiseaseBreaking: A new Alzheimer's drug has been cleared for use in the U.S. Doctors say it could transform the way the disease is treated.
続きを読む »